Mike Polark
Stock Analyst at Wolfe Research
(3.34)
# 943
Out of 4,865 analysts
74
Total ratings
47.92%
Success rate
4.23%
Average return
Main Sectors:
Stocks Rated by Mike Polark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBNX Beta Bionics | Initiates: Outperform | $20 | $18.23 | +9.71% | 1 | May 30, 2025 | |
| LIVN LivaNova | Upgrades: Outperform | $60 | $44.33 | +35.35% | 9 | May 20, 2025 | |
| PODD Insulet | Upgrades: Outperform | $350 | $304.39 | +14.98% | 4 | May 13, 2025 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $230 → $236 | $127.25 | +85.46% | 7 | May 6, 2025 | |
| IRTC iRhythm Technologies | Maintains: Outperform | $133 → $150 | $144.85 | +3.56% | 8 | May 2, 2025 | |
| KMTS Kestra Medical Technologies | Initiates: Outperform | $29 | $15.07 | +92.44% | 1 | Mar 31, 2025 | |
| EW Edwards Lifesciences | Downgrades: Underperform | $60 | $73.27 | -18.11% | 4 | Jan 16, 2025 | |
| RMD ResMed | Downgrades: Underperform | $180 | $250.09 | -28.03% | 5 | Sep 18, 2024 | |
| ZBH Zimmer Biomet Holdings | Initiates: Peer Perform | n/a | $90.21 | - | 1 | Sep 10, 2024 | |
| SYK Stryker | Initiates: Outperform | $405 | $373.37 | +8.47% | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $487 → $503 | $512.11 | -1.78% | 7 | Jul 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Peer Perform | n/a | $132.28 | - | 4 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $117.53 | - | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $121 | $81.83 | +47.87% | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $20.08 | - | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $25 | $10.95 | +128.31% | 4 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $165 | $159.43 | +3.49% | 3 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $101.73 | - | 2 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | n/a | $86.17 | - | 2 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $10.78 | +20.59% | 2 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | $21 | $7.73 | +171.67% | 1 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $250 | $237.08 | +5.45% | 2 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $43 | $1.55 | +2,674.19% | 1 | Sep 2, 2020 |
Beta Bionics
May 30, 2025
Initiates: Outperform
Price Target: $20
Current: $18.23
Upside: +9.71%
LivaNova
May 20, 2025
Upgrades: Outperform
Price Target: $60
Current: $44.33
Upside: +35.35%
Insulet
May 13, 2025
Upgrades: Outperform
Price Target: $350
Current: $304.39
Upside: +14.98%
Inspire Medical Systems
May 6, 2025
Maintains: Outperform
Price Target: $230 → $236
Current: $127.25
Upside: +85.46%
iRhythm Technologies
May 2, 2025
Maintains: Outperform
Price Target: $133 → $150
Current: $144.85
Upside: +3.56%
Kestra Medical Technologies
Mar 31, 2025
Initiates: Outperform
Price Target: $29
Current: $15.07
Upside: +92.44%
Edwards Lifesciences
Jan 16, 2025
Downgrades: Underperform
Price Target: $60
Current: $73.27
Upside: -18.11%
ResMed
Sep 18, 2024
Downgrades: Underperform
Price Target: $180
Current: $250.09
Upside: -28.03%
Zimmer Biomet Holdings
Sep 10, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $90.21
Upside: -
Stryker
Sep 10, 2024
Initiates: Outperform
Price Target: $405
Current: $373.37
Upside: +8.47%
Jul 19, 2024
Maintains: Outperform
Price Target: $487 → $503
Current: $512.11
Upside: -1.78%
Jul 21, 2023
Upgrades: Peer Perform
Price Target: n/a
Current: $132.28
Upside: -
Apr 26, 2023
Downgrades: Peer Perform
Price Target: n/a
Current: $117.53
Upside: -
Jan 26, 2023
Initiates: Outperform
Price Target: $121
Current: $81.83
Upside: +47.87%
Jan 26, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $20.08
Upside: -
Jan 11, 2023
Upgrades: Outperform
Price Target: $25
Current: $10.95
Upside: +128.31%
Sep 15, 2022
Upgrades: Outperform
Price Target: $165
Current: $159.43
Upside: +3.49%
Jul 6, 2022
Initiates: Outperform
Price Target: n/a
Current: $101.73
Upside: -
Jul 6, 2022
Initiates: Underperform
Price Target: n/a
Current: $86.17
Upside: -
Apr 6, 2022
Initiates: Outperform
Price Target: $13
Current: $10.78
Upside: +20.59%
Apr 6, 2022
Initiates: Peer Perform
Price Target: $21
Current: $7.73
Upside: +171.67%
Aug 11, 2021
Maintains: Outperform
Price Target: $230 → $250
Current: $237.08
Upside: +5.45%
Sep 2, 2020
Initiates: Neutral
Price Target: $43
Current: $1.55
Upside: +2,674.19%